Nebenwirkungen · Jalra
Jalra 50 mg tablets · Abschnitt 4.8 · PDF-Seite 6
HOS-121522 · Präparat HOS-095381
System organ class - adverse reaction Frequency Infections and infestations Nasopharyngitis Very common Upper respiratory tract infection Common Metabolism and nutrition disorders Hypoglycaemia Uncommon Nervous system disorders Dizziness Common Headache Common Tremor Common Eye disorders Vision blurred Common Gastrointestinal disorders Constipation Common Nausea Common Gastro-oesophageal reflux disease Common Diarrhoea Common Abdominal pain, including upper Common Vomiting Common Flatulence Uncommon Pancreatitis Rare Hepatobiliary disorders Hepatitis Not known* Skin and subcutaneous tissue disorders Hyperhidrosis Common Rash Common Pruritis Common Dermatitis Common Urticaria Uncommon Exfoliative and bullous skin lesions, including bullous pemphigoid Not known* Cutaneous vasculitis Not known* Musculoskeletal and connective tissue disorders Arthralgia Common Myalgia Common Reproductive system and breast disorders Erectile dysfunction Uncommon
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-05T17:40:00Z · SHA-256 2774ded8af10921f67144f42edf6cdaba1e0f6b6596550e333da1d6bea5ae9fe · Passage 009cc826a43eea596578b052344222651f6ea6f5cd7df645728751251da1e834 · Zeichen 1587–3980 im Abschnitt